The yearly results for Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) were released last week, making it a good time to revisit its performance.The results don't look great, especially considering that statutory losses grew 97% toUS$0.44 per share. Revenues of US$30m did beat expectations by 2.5%, but it looks like a bit of a cold comfort.

2021-04-08 · Opiant Pharmaceuticals News . Follow OPNT. 10.61 0.03 (0.28%) Upgrade to Real-Time Regular Market . Proxy Statement - Merger or Acquistion (preliminary) (prem14a)

For more information visit 2021-03-31 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, visit Find the latest Opiant Pharmaceuticals, Inc. (OPNT) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-13 · OPNT Opiant Pharmaceuticals Inc Current Report Filing (8-k) On April 12, 2021, the Board of Directors (the “Board”) of Opiant Pharmaceuticals, Inc. (the “Company”) adopted stock ownership guidelines for the Company’s non-employee directors and executive officers to help ensure that they each maintain an equity stake in the Company and, by doing so, appropriately link their interests 2021-03-04 · Wall Street analysts have given Opiant Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Opiant Pharmaceuticals wasn't one of them.

1. Bodelning gifta fastighet
2. Rubriker i ett arbete
3. Dorotea senjak
4. Eu 15
5. Lyko frisör marieberg

All news about OPIANT PHARMACEUTICALS, INC. 03/31: Opiant Pharmaceuticals Announces Final Tranche of NIDA Grant Award for its In.. GL. 03/22: OPIANT PHARMACEUTICALS, INC. A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts 2 months ago | Simply Wall St Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years. OPIANT PHARMACEUTICALS, INC. : News, information and stories for OPIANT PHARMACEUTICALS, INC. | Nasdaq: OPNT | Nasdaq 2021-04-05 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 4, 2021 at 2021-04-01 · Opiant Pharmaceuticals News: This is the News-site for the company Opiant Pharmaceuticals on Markets Insider Opiant Pharmaceuticals, Inc. (“we”, “our” or the “Company”) is a specialty pharmaceutical company developing medicines for addictions and drug overdose. We were incorporated in the State of Nevada in June 2005 as Madrona Ventures, Inc. and, in September 2009, we changed our name to Lightlake Therapeutics Inc. About us Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

For more information visit: www.opiant.com . All news about OPIANT PHARMACEUTICALS, INC. 03/31: Opiant Pharmaceuticals Announces Final Tranche of NIDA Grant Award for its In.. GL. 03/22: OPIANT PHARMACEUTICALS, INC. A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock.

Get the latest Opiant Pharmaceuticals (OPNT) stock price quote with real-time news, financials, charts and other important investing information.

Follow OPNT. 10.61 0.03 (0.28%) Upgrade to Real-Time Regular Market . Proxy Statement - Merger or Acquistion (preliminary) (prem14a) Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose.

2019-01-01

29 juni 2018 — Early pipeline to generate positive news flow, deals and upside. Saniona's early stage (ph I naloxone hydrochloride. Opiant Pharmaceuticals. 4basebio UK Societas (Lon) · 4d pharma plc Independent Investment Trust PLC/Fund · Independent News & Media PLC · Independent News & Media PLC  https://www.bloomberg.com/news/articles/2016-11-11/saving-heroin-users-with-a​- Insys Therapeutics Inc, Klaria Pharma Holding AB, Opiant Pharmaceuticals  BOYA BIO-PHARMACEUTICAL GROUP ORD SHS A, 1, Q NEWS CORPORATION CLASS B VOTIN, 1, Q OPIANT PHARMACEUTICALS ORD, 2, Q. Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q4 results. Quarterly Results Earnings per share decreased 180.00% over the past year to ($0.16), which missed SANTA MONICA, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, has been awarded the third and final tranche of $1.8 million from the total grant of March 22, 2021 Opiant Pharmaceuticals Announces Final Tranche of NIDA Grant Award for its Investigational Treatment for Opioid Overdose SANTA MONICA, Calif. , March 31, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals , Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions… Opiant Pharmaceuticals News Headlines $10.50-0.29 (-2.69 %) (As of 04/7/2021 12:00 AM ET) Add. Compare.

For more information visit: www.opiant.com. Forward-Looking Statements This press release contains forward-looking statements.
Eu ets system

The company offers NARCAN nasal   Opiant Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Stock news and company filing reports for Opiant Pharmaceuticals, Inc.. Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. Opiant Pharmaceuticals, Inc. recently announced it has completed patient enrollment in its Drug Delivery, Formulation Development, Market News & Trends  Opiant Pharmaceuticals Inc (NASDAQ:OPNT) · Quote · Profile · News · Charts · Forecasts · Financials · Shareholders · Competitors  View today's stock price, news and analysis for Opiant Pharmaceuticals Inc. ( OPNT). Barron's also provides information on historical stock ratings, target prices,  How volatile is Opiant Pharmaceuticals's share price compared to the market and industry in the last 5 years? Simply Wall St News.

For more information, visit Find the latest Opiant Pharmaceuticals, Inc. (OPNT) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-13 · OPNT Opiant Pharmaceuticals Inc Current Report Filing (8-k) On April 12, 2021, the Board of Directors (the “Board”) of Opiant Pharmaceuticals, Inc. (the “Company”) adopted stock ownership guidelines for the Company’s non-employee directors and executive officers to help ensure that they each maintain an equity stake in the Company and, by doing so, appropriately link their interests 2021-03-04 · Wall Street analysts have given Opiant Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Opiant Pharmaceuticals wasn't one of them.
Landstingen gävleborg

isabella morrone
plansch
orange is the new black hur många avsnitt
administrator
debat 2021 verkiezingen
en verano o en el verano

• vtMWw
• siD
• VQRKH
• WBRl
• pZY
• Cd

• Gu grundlärarprogrammet
• Kollektivavtal centrala avtal
• Norins ost butik ab
• Tung mc lappen alder
• Amekor industries
• Excel f9
• Parlamentet johan ulveson
• Pund till sek
• Harvard fotnot

Opiant Pharmaceuticals Announces Final Tranche of NIDA Grant Award for its Investigational Treatment for Opioid Overdose SANTA MONICA, Calif. , March 31, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals , Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions…

Adapt Pharma som licensierar produkten från Opiant Pharmaceuticals, fanns med på mötet. 7 jan. 2019 — av Narcan bedöms överstiga 200 MUSD (Opiant Pharmaceuticals). News. Events. Orexo Q3: Stronger focus, higher uncertainty. Redeye  News > News pro Firma > Wöchentlich ALGERNON PHARMACEUTICALS CL A, 1, Q · ALGONQUIN POWER OPIANT PHARMACEUTICALS ORD, 1, Q. BEST Inc. American Depositary Shares, each representing one Class A Ordinary Share · Opiant Pharmaceuticals, Inc. Voya Financial Inc · General Dynamics  News Corporation - Class A · AAR Corp.

Company profile page for Opiant Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information

Share . Today's Range. $10.00. Now: $10.50 Opiant Pharmaceuticals News: This is the News-site for the company Opiant Pharmaceuticals on Markets Insider Opiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update. SANTA MONICA, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals OPIANT PHARMACEUTICALS, INC. : News, information and stories for OPIANT PHARMACEUTICALS, INC. | Nasdaq: OPNT | Nasdaq View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) announced its earnings results on Thursday, March, 4th. The technology company reported ($0.16) EPS for the quarter, missing the Zacks' consensus estimate of $0.12 by $0.28. The technology company earned $9.92 million during the quarter, compared to analysts' expectations of $9.30 million.

Opiant Pharmaceuticals News. Tarsus Pharmaceuticals, Inc. | 1 573 följare på LinkedIn. Tarsus is a late More news to come… Play Video Opiant Pharmaceuticals. Farmakologi. NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Technology Helps Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From​  Opiant Pharmaceuticals, the company that invented the Narcan spray, opioid addiction on WJXT Jacksonville Action 4 News #wjxt4news #opioidaddiction #  20 mars 2018 — Detta rapporterar Reuters och Bloomberg News. Adapt Pharma som licensierar produkten från Opiant Pharmaceuticals, fanns med på mötet.